| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.8M | — | +9.4% |
| Cost of Revenue | $4.3M | — | +60.3% |
| Gross Profit | $4.5M | — | -15.8% |
| R&D Expense | $920K | — | +71.2% |
| SG&A Expense | $3.5M | — | +6.4% |
| Pre-tax Income | -$2.1M | — | -402.2% |
| Income Tax | -$480K | — | -358.3% |
| Net Income | -$1.6M | — | -418.6% |
| EPS (Basic) | -$0.03 | — | -400.0% |
| EPS (Diluted) | -$0.03 | — | -400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.3M | +34.6% | +36.3% |
| Accounts Receivable | $3.7M | +394.2% | +77.1% |
| Current Assets | $22.1M | +36.7% | +41.8% |
| Total Assets | $29.0M | +25.4% | +35.8% |
| Current Liabilities | $7.0M | +36.7% | +4.3% |
| Total Liabilities | $7.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | -729.4% |
| Investing Cash Flow | -$362K | — | +48.5% |
| Financing Cash Flow | $6.3M | — | +6560.3% |
| +2.7% |
| Stockholders' Equity | $21.6M | +26.2% | +52.6% |